UBS Group’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-94
Closed -$77 9087
2023
Q3
$77 Buy
94
+61
+185% +$50 ﹤0.01% 7789
2023
Q2
$30 Hold
33
﹤0.01% 7571
2023
Q1
$25 Sell
33
-1,360
-98% -$1.03K ﹤0.01% 8302
2022
Q4
$3.5K Sell
1,393
-9,233
-87% -$23.2K ﹤0.01% 8304
2022
Q3
$15K Buy
10,626
+10,593
+32,100% +$15K ﹤0.01% 6762
2022
Q2
$0 Hold
33
﹤0.01% 10051
2022
Q1
$0 Buy
33
+7
+27% ﹤0.01% 9877
2021
Q4
$0 Sell
26
-5,150
-99% ﹤0.01% 9611
2021
Q3
$13K Buy
5,176
+2,907
+128% +$7.3K ﹤0.01% 6564
2021
Q2
$6K Sell
2,269
-467
-17% -$1.24K ﹤0.01% 7374
2021
Q1
$9K Buy
2,736
+604
+28% +$1.99K ﹤0.01% 7002
2020
Q4
$6K Buy
2,132
+2,106
+8,100% +$5.93K ﹤0.01% 6761
2020
Q3
$0 Buy
26
+15
+136% ﹤0.01% 7509
2020
Q2
$0 Sell
11
-10,342
-100% ﹤0.01% 7409
2020
Q1
$21K Buy
10,353
+1,173
+13% +$2.38K ﹤0.01% 5568
2019
Q4
$37K Buy
9,180
+5,350
+140% +$21.6K ﹤0.01% 5475
2019
Q3
$12K Buy
3,830
+3,582
+1,444% +$11.2K ﹤0.01% 6103
2019
Q2
$1K Buy
+248
New +$1K ﹤0.01% 6878
2018
Q4
Sell
-2,276
Closed -$70K 7284
2018
Q3
$70K Buy
2,276
+847
+59% +$26.1K ﹤0.01% 5008
2018
Q2
$31K Buy
+1,429
New +$31K ﹤0.01% 5446
2018
Q1
Sell
-1,337
Closed -$19K 7129
2017
Q4
$19K Buy
+1,337
New +$19K ﹤0.01% 5636
2017
Q3
Sell
-787
Closed -$5K 6956
2017
Q2
$5K Sell
787
-116
-13% -$737 ﹤0.01% 6194
2017
Q1
$7K Sell
903
-491
-35% -$3.81K ﹤0.01% 5915
2016
Q4
$13K Buy
1,394
+935
+204% +$8.72K ﹤0.01% 5819
2016
Q3
$15K Buy
+459
New +$15K ﹤0.01% 5629
2016
Q2
Sell
-500
Closed -$12K 6967
2016
Q1
$12K Buy
+500
New +$12K ﹤0.01% 5706
2015
Q4
Sell
-198
Closed -$6K 7055
2015
Q3
$6K Hold
198
﹤0.01% 6208
2015
Q2
$7K Buy
198
+102
+106% +$3.61K ﹤0.01% 6170
2015
Q1
$4K Buy
96
+22
+30% +$917 ﹤0.01% 6287
2014
Q4
$4K Buy
+74
New +$4K ﹤0.01% 6440